Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Morel

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Revue De L'Infirmiere|January 15, 2018
[Addictology, promoting users' power to act]Alain Morel
Therapie|June 22, 2007
[Detection of dihydropyrimidine dehydrogenase deficiency before treatment by fluoropyrimidines]Erick Gamelin, Michèle Boisdron-Celle, Alain Morel
Bulletin Du Cancer|February 24, 2006
[Oxaliplatin neurotoxicity]Laurence Gamelin, Michèle Boisdron-Celle, Alain Morel, et al.
International Journal of Environmental Research and Public Health|April 30, 2021
The Efficacy of Primavera, a Prevention Programme on Alcohol and Tobacco Use among 10-12-Year-Old Schoolchildren: A Randomized Controlled Cluster StudyCristina Diaz Gomez, Alain Morel, Isabelle Sedano, et al.
Diagnostics (Basel, Switzerland)|August 6, 2020
Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and PyrosequencingAmandine Billaud, Veronique Verriele, Jonathan Dauvé, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 20, 2005
An accurate dihydrouracil/uracil determination using improved high performance liquid chromatography method for preventing fluoropyrimidines-related toxicity in clinical practiceGaëlle Remaud, Michèle Boisdron-Celle, Catherine Hameline, et al.
Bulletin Du Cancer|October 19, 2020
[Genetic instability, a factor limiting the efficiency of targeted therapies in solid oncology]Amandine Billaud, Louise-Marie Chevalier, Mario Campone, et al.
Neuropharmacology|July 23, 2003
The modulatory effects of the anxiolytic etifoxine on GABA(A) receptors are mediated by the beta subunitAlain Hamon, Alain Morel, Bernard Hue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patientsElisabeth Rouits, Michèle Boisdron-Celle, Agnès Dumont, et al.
Clinical Colorectal Cancer|June 12, 2012
Individual fluorouracil dose adjustment in FOLFOX based on pharmacokinetic follow-up compared with conventional body-area-surface dosing: a phase II, proof-of-concept studyOlivier Capitain, Andreaa Asevoaia, Michele Boisdron-Celle, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Revue De L'Infirmiere|January 15, 2018
[Addictology, promoting users' power to act]Alain Morel
Therapie|June 22, 2007
[Detection of dihydropyrimidine dehydrogenase deficiency before treatment by fluoropyrimidines]Erick Gamelin, Michèle Boisdron-Celle, Alain Morel
Bulletin Du Cancer|February 24, 2006
[Oxaliplatin neurotoxicity]Laurence Gamelin, Michèle Boisdron-Celle, Alain Morel, et al.
International Journal of Environmental Research and Public Health|April 30, 2021
The Efficacy of Primavera, a Prevention Programme on Alcohol and Tobacco Use among 10-12-Year-Old Schoolchildren: A Randomized Controlled Cluster StudyCristina Diaz Gomez, Alain Morel, Isabelle Sedano, et al.
Diagnostics (Basel, Switzerland)|August 6, 2020
Non-Small-Cell Lung Cancer-Sensitive Detection of the p.Thr790Met EGFR Alteration by Preamplification before PNA-Mediated PCR Clamping and PyrosequencingAmandine Billaud, Veronique Verriele, Jonathan Dauvé, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 20, 2005
An accurate dihydrouracil/uracil determination using improved high performance liquid chromatography method for preventing fluoropyrimidines-related toxicity in clinical practiceGaëlle Remaud, Michèle Boisdron-Celle, Catherine Hameline, et al.
Bulletin Du Cancer|October 19, 2020
[Genetic instability, a factor limiting the efficiency of targeted therapies in solid oncology]Amandine Billaud, Louise-Marie Chevalier, Mario Campone, et al.
Neuropharmacology|July 23, 2003
The modulatory effects of the anxiolytic etifoxine on GABA(A) receptors are mediated by the beta subunitAlain Hamon, Alain Morel, Bernard Hue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patientsElisabeth Rouits, Michèle Boisdron-Celle, Agnès Dumont, et al.
Clinical Colorectal Cancer|June 12, 2012
Individual fluorouracil dose adjustment in FOLFOX based on pharmacokinetic follow-up compared with conventional body-area-surface dosing: a phase II, proof-of-concept studyOlivier Capitain, Andreaa Asevoaia, Michele Boisdron-Celle, et al.
Pageof 7